Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 4Stomach Neoplasms 1Squamous Intraepithelial Lesions 1Smoldering Multiple Myeloma 1Psychological Well-Being 1Ovarian Neoplasms 1Muscle Invasive Bladder Cancer (MIBC) 1Multiple Myeloma 1Motor Activity 1Monoclonal Gammopathy of Undetermined Significance 1Malnutrition 1Lung Neoplasms 1Limited Stage Small Cell Lung Cancer 1Inflammation 1Helicobacter Infections 1Esophageal Neoplasms 1Diarrhea 1Colorectal Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Colposcopy 2epigallocatechin gallate 1calcipotriene 1VGX-3100 1Restraint, Physical 1Probiotics 1Mass Screening 1Imiquimod 1Human Papillomavirus DNA Tests 1Fluorouracil 1Electroporation Therapies 1Electroporation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Intraepithelial Lesions × Probiotics × 1 year × Clear all
NCT06949800 2026-05-01

CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial

University of California, San Francisco

Phase 2 Not yet recruiting
90 enrolled
Gynecologic

Squamous Intraepithelial Lesions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡